Individualized Treatment Strategy for Cutaneous Melanoma: Where Are We Now and Where Are We Going?
In the past several decades, innovative research in cancer biology and immunology has contributed to novel therapeutics, such as targeted therapy and immunotherapy, which have transformed the management of patients with melanoma. Despite the remarkable therapeutic outcomes of targeted treatments tar...
Guardado en:
Autores principales: | Huihua Zeng, Fen Liu, Hairong Zhou, Changchun Zeng |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c6c121b0e76045d8b48f1af45349f876 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Melanoma Immunotherapy and Precision Medicine in the Era of Tumor Micro-Tissue Engineering: Where Are We Now and Where Are We Going?
por: Francesca Varrone, et al.
Publicado: (2021) -
Natural Products and Synthetic Biology: Where We Are and Where We Need To Go
por: Sylvia Kunakom, et al.
Publicado: (2019) -
Dermatology education in skin of colour: where we are and where do we go?
por: Joshua Onasanya, et al.
Publicado: (2021) -
Chemokine Pathways in Cutaneous Melanoma: Their Modulation by Cancer and Exploitation by the Clinician
por: Rebecca Adams, et al.
Publicado: (2021) -
Exercise-induced pulmonary hemorrhage: where are we now?
por: Poole DC, et al.
Publicado: (2016)